A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts
- 111 Downloads
There is a need for better definition of polyarteritis nodosa (PAN) subphenotypes and the influence of ethnicity and geography. This study is aimed to study the demographic and clinical features of PAN cohorts from the UK and Turkey (TR) and to compare and contrast disease characteristics. A retrospective survey of databases from two vasculitis centres between 1990 and 2016 for PAN patients fulfilling the EMEA Vasculitis Classification algorithm. All paediatric-onset adult patients met the Ankara 2008 (EULAR/PReS endorsed) criteria for childhood PAN. Those with typical angiographic and/or histopathologic findings consistent with PAN were included. 93 (M/F: 51/42) patients (UK: 47, TR: 46) were included. Three were HBV-related, 20 (21.5%) had paediatric onset and 16 (16.5%), cutaneous PAN. TR patients had younger age of disease onset 44 (28.5–59.0) vs. 24.5 (11.8–40.5), p = 0.002. Twelve (26%) of TR patients had monogenic disease (Familial Mediterranean Fever association (n = 7), deficiency of adenosine deaminase 2, DADA2, (n = 5). No difference was found in phenotype between paediatric and adult onset patients except for frequency of cutaneous lesions (p = 0.002). During a median 67.5 (32–126) months follow-up, 13 patients died (12.7% in UK vs. 15.2% in Turkish cohorts). No difference was found between two cohorts in relation to relapse rate, death and vasculitis damage index. This study defined a diagnosis of PAN according to the EMEA algorithm. The TR group had a younger age of disease onset and more cases of monogenic disease; however, disease extent, relapse rate, damage index and death rates were similar between groups.
KeywordsPolyarteritis nodosa (PAN) Vasculitis Familial Mediterranean Fever (FMF) Deficiency of adenosine deaminase 2 (DADA2) Paediatric PAN EMEA vasculitis classification
OK, AE, YB, SG, AS, BA, İE, SO, DJ Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work. OK, AE, YB, SG, AS, BA, İE, SO, DJ Drafting the work or revising it critically for important intellectual content. OK, AE, YB, SG, AS, BA, İE, SO, DJ Final approval of the version to be published. OK, AE, YB, SG, AS, BA, İE, SO, DJ Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
- 1.Kussmaul A, Maier R (1866) Ueber eine bisher nicht beschriebene eigenthu ̈mliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskel- l ̈ahmung einhergeht. Dtsch Arch Klin Med 1:484–518Google Scholar
- 2.Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V et al (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62(2):616–626CrossRefPubMedGoogle Scholar
- 8.Erden A, Batu ED, Bilgin E, Armagan B, Karadag O, Ozen S et al (2016) Comparing the characteristics of adult and pediatric patients with polyarteritis nodosa. Ann Rheum Dis 75:799Google Scholar
- 19.Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P et al, French Vasculitis Study Group (2001) Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44:666–675CrossRefPubMedGoogle Scholar
- 21.Samson M, Puéchal X, Mouthon L, Devilliers H, Cohen P, Bienvenu B et al, French Vasculitis Study Group (FVSG) (2017) Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial. Clin Exp Rheumatol 35(Suppl 103):176–184PubMedGoogle Scholar